That’s the question raised in this Hit and Run post by Jacob Sullum.

These developments, while a boon to patients, will pose a challenge to the drug policy reform movement, which has gotten a lot of mileage out of the federal government’s cruel, know-nothing intransigence on the issue of medical marijuana. Once legal, equally effective […]